ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2070

Activated Tendon Stromal Cells Drive a Type 17 Immune Response Via CCL20: A Potential Role in the Pathogenesis of Enthesitis in Psoriatic Arthritis

Emma Garcia-Melchor1, Giacomo Cafaro2,3, Moeed Akbar1, Derek Gilchrist1, Susan M Kitson1, Stefan Siebert4, Iain B. McInnes5 and Neal L Millar1, 1Institute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow, United Kingdom, 2Institute of Infection, Immunity and Inflammation, University of Glasgow, Glagow, United Kingdom, 3Rheumatology Unit, Department of Medicine, University of Perugia, Perugia, Italy, 4Institute of Infection, Immunity and Inflammation, University of Glasgow, Cardiff, United Kingdom, 5Immunology, Infection and Inflammation, University of Glasgow, Glasgow, United Kingdom

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: Cell Migration, chemokines and psoriatic arthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, October 23, 2018

Title: Spondyloarthritis Including Psoriatic Arthritis – Basic Science Poster

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: While the exact pathogenesis of psoriatic arthritis (PsA) remains unclear, it is recognised that several environmental factors operate in individuals with genetic susceptibility leading to sustained inflammatory responses. These involve both the innate and adaptive immune system with IL23/IL17 axis playing a central role. One suggested environmental factor is mechanical stress and accordingly, involvement of entheseal sites exposed to maximal biomechanical loading is a common feature of PsA. However, the mechanisms linking mechanical stress/damage at the enthesis/tendon which leads to immune cell activation remains unknown. We aimed to interrogate the role of tendon stromal cells (tenocytes) in the induction of a type 17 response.

Methods: Immunohistochemical staining for CCR6 was performed in paraffin embedded PsA synovial membrane and the presence of CCL20 was quantified in synovial fluid (SF) from PsA and osteoarthritis (OA) patients by ELISA. Healthy tenocytes cultured from hamstring tendons and fibroblast-like synoviocytes (FLS) from PsA patients were stimulated with human IL-1β (1 ng/ml) and IL-17A (1, 10 and 100 ng/ml). Expression of CCL20 transcript and protein upon stimulation were assessed by qPCR and ELISA, respectively. T cell migration assays were performed with magnetically enriched CD3+ cells from peripheral blood of PsA patients and healthy controls using a Transwell system.

Results: We observed an abundance of CCR6 positive cells in PsA synovial membrane and higher levels of CCL20 in SF from PsA patients compared with OA (OA mean+/-SEM 40.91+/-30.06 pg/ml, n=14; PsA 339.5+/-100.7 pg/ml, n=39; p<0.0001). Tenocytes were able to upregulate CCL20 transcript (fold change 680.5+/-215.2; p<0.0001, n=5) and produce CCL20 (481.8+/- 84.26 pg/ml; p<0.0001, n=13), following stimulation with IL-1β. In this context, the addition of IL-17A induced a synergistic effect with IL-1β in both tenocytes and PsA FLS. Conditioned media from tenocytes promoted T cell migration.

Conclusion: Activated tendon stromal cells and PsA synovial fibroblasts are able to produce CCL20, a chemokine that binds to CCR6 and is responsible for the recruitment of IL-17 producing cells. In conclusion, our results support a role of the tendon stromal compartment in the development of a type 17 immune response in PsA.


Disclosure: E. Garcia-Melchor, None; G. Cafaro, None; M. Akbar, None; D. Gilchrist, None; S. M. Kitson, None; S. Siebert, Pfizer, Inc., 2, 5, 8,Janssen, 2, 5, 8,Bristol-Myers Squibb, 2,Celgene Corporation, 2, 5, 8,UCB, Inc., 2, 5, 8, 9,Boehringer Ingelheim, 2, 5, 8,Novartis, 5, 8, 9,AbbVie Inc., 9; I. B. McInnes, None; N. L. Millar, Novartis, 5.

To cite this abstract in AMA style:

Garcia-Melchor E, Cafaro G, Akbar M, Gilchrist D, Kitson SM, Siebert S, McInnes IB, Millar NL. Activated Tendon Stromal Cells Drive a Type 17 Immune Response Via CCL20: A Potential Role in the Pathogenesis of Enthesitis in Psoriatic Arthritis [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/activated-tendon-stromal-cells-drive-a-type-17-immune-response-via-ccl20-a-potential-role-in-the-pathogenesis-of-enthesitis-in-psoriatic-arthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/activated-tendon-stromal-cells-drive-a-type-17-immune-response-via-ccl20-a-potential-role-in-the-pathogenesis-of-enthesitis-in-psoriatic-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology